DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Hypersomnia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hypersomnia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hypersomnia development. The report provides detailed ...
January 2020
60 pages
Hyperuricemia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hyperuricemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hyperuricemia development. The report provides detailed ...
January 2020
60 pages
Hypoglycemia - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Hypoglycemia - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Hypoglycemia development. The report provides detailed ...
January 2020
60 pages
Idiopathic Short Stature - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Idiopathic Short Stature The report also ...
January 2020
60 pages
Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Idiopathic Thrombocytopenic Purpura The report also ...
January 2020
90 pages
Impetigo - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Impetigo - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Impetigo development. The report provides detailed ...
January 2020
60 pages
Intermittent Claudication - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Intermittent Claudication - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Intermittent Claudication development. The report provides ...
January 2020
60 pages
Iron Deficiency Anemia - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Iron Deficiency Anemia The report also ...
January 2020
90 pages
Ischemia Reperfusion Injury - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Ischemia Reperfusion Injury The report also ...
January 2020
120 pages
Ischemic Stroke - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Ischemic Stroke - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Ischemic Stroke development. The report provides ...
January 2020
60 pages
Juvenile Rheumatoid Arthritis - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Juvenile Rheumatoid Arthritis The report also ...
January 2020
60 pages
Klebsiella Pneumoniae Infections - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Klebsiella Pneumoniae Infections The report also ...
January 2020
60 pages
Left Ventricular Dysfunction - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Left Ventricular Dysfunction The report also ...
January 2020
60 pages
Leishmaniasis - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Leishmaniasis - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Leishmaniasis development. The report provides detailed ...
January 2020
60 pages
Liver Failure - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Liver Failure - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Liver Failure development. The report provides ...
January 2020
60 pages
Male Hypogonadism - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Male Hypogonadism - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Male Hypogonadism development. The report provides ...
January 2020
60 pages
Male Infertility - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Male Infertility - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Male Infertility development. The report provides ...
January 2020
60 pages
Malignant Glioma - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Malignant Glioma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Malignant Glioma development. The report provides ...
January 2020
60 pages
Malignant Mesothelioma - Pipeline Insight, 2020
US$ 1,250.00
... clients within 48 Hours 'Malignant Mesothelioma - Pipeline Insight, 2019' report by DelveInsight offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Malignant Mesothelioma development. The report provides ...
January 2020
60 pages
Medullary Thyroid Cancer - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Medullary Thyroid Cancer The report also ...
January 2020
60 pages
Metastatic Hepatocellular Carcinoma - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Hepatocellular Carcinoma The report also ...
January 2020
60 pages
Metastatic Liver Cancer - Pipeline Insight, 2020
US$ 1,250.00
... and chemical information Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Metastatic Liver Cancer The report also ...
January 2020
60 pages
